The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
This marks the fourth acquisition by Corona Remedies from multinational corporations
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Subscribe To Our Newsletter & Stay Updated
